恶性淋巴瘤中医证分型与外周血T细胞亚群的相关性研究.pdfVIP

lymphoma 80 T CD4CD8CD4/CD8 T T CD4CD8CD4/CD8 T CD4CD8CD4/CD8 80 420 T 1ml,EDTA-K2 PBMNC CD4CD8CD4/CD8 EDTA-K2 0.1mlCD4CD8CD4/CD8 20 l,30, , BECKMAN COULTEREpics-XL 15mW488nmExpo 32 ADC Muticycle AVDNAflow-check TMFluorpheres(10 m)REF 6605359.Beckman 5 Coulter,Inc.Fullerton,CA 92835. CV2 CD4CD8CD4/CD8 :CD4CD8CD4/CD8 (P005)CD4 (P005) CD8 (P005)(P005) CD4/CD8 (P005) CD4CD8 CD4/CD8 CD4 P0.05 CD4 CD4;CD8 P0.05 CD4CD8 CD4 CD8 CD4/CD8 6 The Relationship between the Differentiation of Symptoms and Signs for classification of Syndrome of TCM and T-lympha group Postgraduate ShaoYaJun Tutor Prof.JingJinBo ABSTRACT In this article, the cognition and contemporary research progress of both TCM and western medicine about malignant lymphoma are discussed, together with the theory evidence of the relationship between the differentiation of symptoms and signs for classification of syndrome of TCM and T-lympha group. And a clinical observation and research based on this topic is carried out. Objective: To explore the dependability between the phenotype for the immune reaction of malignant lymphoma and the differentiation of symptoms and signs for classification of syndrome of TCM. To provide the evidence of malignant lymphoma in cellular immunology and to research the relationship between CD4 and malignant lymphoma. Method: Choose 80 patients who fit the dia